Delivery Order SPE2DB20D3103-SPE2DB25FN0V3
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$66K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of BUPROPION HCL XL 150 MG TABLET 500S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $3,941.46 and an ultimate completion date of April 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,384.18 Firm Fixed Price Delivery Order contract is for the provision of 4567363926 - BUPROPION HCL XL 300 MG TABLET 500S. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The federal contract award described is for the delivery of BUPROPION HCL XL 300 MG TABLET 500S to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $20,883.37, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with an ultimate completion date of January 4, 2024. The contract was awarded on January 3, 2024 and does not have a set-aside designation,...
This federal contract award, valued at $86,361.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of January 24, 2024. The contract covers the delivery of 4563416633 - BUPROPION HCL XL 150 MG TABLET 500S, a generic pharmaceutical product, to support military and government healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,887.46, is for the delivery of 4564466378 - BUPROPION HCL XL 300 MG TABLET 500S. It is a Firm Fixed Price delivery order contract type with a performance period through May 2, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of BUPROPION HCL XL 300 MG TABLET 500S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $105,516.75 and a performance period ending on February 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of 4564247365 - Bupropion HCL XL 150 mg Tablets in 500 count bottles to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price Delivery Order has a ceiling value of $54,382.63 and a period of performance through April 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate indefinite delivery contract (IDC) with...
This federal contract award is for the delivery of pharmaceutical products, specifically BUPROPION HCL XL 300 MG TABLET, to the Defense Logistics Agency (DLA). The $86,987.29 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 16, 2023, with a completion date of November 17, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $63,780.64, for the supply of 4564416340 - Bupropion HCL XL 300 MG Tablets in quantities of 500s. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...